BackAlnylam Pharmaceuticals Overview

Alnylam Pharmaceuticals Total Revenue

Revenue analysis for ALNY.

Quarterly Revenue

$1.17B
↑ 96.43% YoY

As of Mar 2026

Annual Revenue (TTM)

$4.29B
↑ 89.07% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin